Product Specifications:

Item# 1004 : Recombinant HIV-1 IIIB Glycoprotein Soluble gp160 

 Concentration: See Vial 

 Mass/Vial: 100µg

 Diluent: PBS In-Vitro Diagnostics

 Purity: >95%

 Stabilizer: None

 Preservative: None

 Storage: -75°C

 Physical State: Frozen Liquid

 Stability: 2 years at -75°C.

 Application: CD4 Binding, Vaccines, T- Cell Activation, In- Vitro Diagonostics.

 Description: Full length Recombinant HIV-1 IIIB soluble - membrane anchor sequence deleted- gp160 glycoprotein produced in the Baculovirus Expression System.

 Purification: This protein is purified by immunoaffinity Chromatography to >95% purity as determined by SDS-PAGE, reduced.

 Specificity: This protein binds to murine monoclonal antibodies of defined epitope specificit and human serum polyclonal antibodies in ELISA and Western ELISA.

 Biological Activity: This protein binds to human T-cell receptor CD4 in ELISA and Western ELISA as determined by CD4/gp160/Anti gp160 mAb-peroxidase capture ELISA. This protein activates human T-Lymphocytes (CD4+, CD4-), in vitro, as measured by RNA synthesis during G0 to G1 transition phase of antigen-binding competent cells.

 Applications and Instructions for use

 Recommended concentrations for use are approximate values. A dose dependent response assay should be performed to determine the optimal concentration for use in specific applications. ELISA and Western ELISA require 10-100ng protein depending on the nature and affinity of the detection reagent. HIV-1 converted human serum polyclonal antibodies yield titers of 1:1000 or greater at 1-10ng of immobilized protein under standard ELISA conditions.

Item#: 1004-P Peroxidase-Conjugated rgp160 HIV-1 IIIB

 Application: Human diagnostics, CD4 binding, Drug screening, Human T-cell CD4 studies.

 Item#: 1004-G Colloidal gold-Conjugated rgp160 HIV-1 IIIB

 Application: Human diagnostics, CD4 binding, Drug screening, FACS analysis. 

 Item#: 1004-F Flourescene-Conjugated rgp160 HIV-1 III

 Application: FACS analysis, Histocytology.

Immunodx供应，ImmunoDX，LLC（IDX）-前身为ImmunoDiagnostics-为人类T细胞研究/诊断，艾滋病，HCV，HBV，TB，癌症和关节炎的诊断和治疗开发开发，制造和销售各种特种生物学产品。